de Vegt F - Search Results

1

Effect of routine follow-up after treatment for laryngeal cancer on life expectancy and mortality: results of a Markov model analysis.

Ritoe SC, de Vegt F, Scheike IM, Krabbe PF, Kaanders JH, van den Hoogen FJ, Verbeek AL, Marres HA. Ritoe SC, et al. Among authors: de vegt f. Cancer. 2007 Jan 15;109(2):239-47. doi: 10.1002/cncr.22401. Cancer. 2007. PMID: 17154185 Free article.

2

No supportive evidence for clinical benefit of routine follow-up in ovarian cancer: a Dutch multicenter study.

Geurts SM, van Altena AM, de Vegt F, Tjan-Heijnen VC, Massuger LF, van Dijck JA, Verbeek AL. Geurts SM, et al. Among authors: de vegt f. Int J Gynecol Cancer. 2011 May;21(4):647-53. doi: 10.1097/IGC.0b013e318212b87d. Int J Gynecol Cancer. 2011. PMID: 21543930

3

Impact of routine follow-up examinations on life expectancy in ovarian cancer patients: a simulation study.

Geurts SM, de Vegt F, van Altena AM, Tjan-Heijnen VC, Massuger LF, Adang EM, van Dijck JA, Verbeek AL. Geurts SM, et al. Among authors: de vegt f. Int J Gynecol Cancer. 2012 Sep;22(7):1150-7. doi: 10.1097/IGC.0b013e3182611451. Int J Gynecol Cancer. 2012. PMID: 22864333

4

Considering early detection of relapsed ovarian cancer: a review of the literature.

Geurts SM, de Vegt F, van Altena AM, van Dijck JA, Tjan-Heijnen VC, Verbeek AL, Massuger LF. Geurts SM, et al. Among authors: de vegt f. Int J Gynecol Cancer. 2011 Jul;21(5):837-45. doi: 10.1097/IGC.0b013e31821bb88c. Int J Gynecol Cancer. 2011. PMID: 21697678 Review.

5

Pattern of follow-up care and early relapse detection in breast cancer patients.

Geurts SM, de Vegt F, Siesling S, Flobbe K, Aben KK, van der Heiden-van der Loo M, Verbeek AL, van Dijck JA, Tjan-Heijnen VC. Geurts SM, et al. Among authors: de vegt f. Breast Cancer Res Treat. 2012 Dec;136(3):859-68. doi: 10.1007/s10549-012-2297-9. Epub 2012 Nov 2. Breast Cancer Res Treat. 2012. PMID: 23117854

6

Trends and projections in the incidence of oesophageal cancer in the Netherlands: An age-period-cohort analysis from 1989 to 2041.

de Vegt F, Gommers JJJ, Groenewoud H, Siersema PD, Verbeek ALM, Peters Y, Broeders MJM. de Vegt F, et al. Int J Cancer. 2022 Feb 1;150(3):420-430. doi: 10.1002/ijc.33836. Epub 2021 Oct 16. Int J Cancer. 2022. PMID: 34605022 Free PMC article.

7

[Aftercare in oncology--greater role for the general practitioner].

de Vegt F, van Dijck JA, van de Lisdonk EH, Verbeek AL. de Vegt F, et al. Ned Tijdschr Geneeskd. 2011;155(45):A4148. Ned Tijdschr Geneeskd. 2011. PMID: 22085581 Dutch.

8

Healthy donor effect: its magnitude in health research among blood donors.

Atsma F, Veldhuizen I, Verbeek A, de Kort W, de Vegt F. Atsma F, et al. Among authors: de vegt f, de kort w. Transfusion. 2011 Aug;51(8):1820-8. doi: 10.1111/j.1537-2995.2010.03055.x. Epub 2011 Feb 22. Transfusion. 2011. PMID: 21342203

9

Entering a new era of body indices: the feasibility of a body shape index and body roundness index to identify cardiovascular health status.

Maessen MF, Eijsvogels TM, Verheggen RJ, Hopman MT, Verbeek AL, de Vegt F. Maessen MF, et al. Among authors: de vegt f. PLoS One. 2014 Sep 17;9(9):e107212. doi: 10.1371/journal.pone.0107212. eCollection 2014. PLoS One. 2014. PMID: 25229394 Free PMC article.

10

Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex.

Hoogendoorn EH, Hermus AR, de Vegt F, Ross HA, Verbeek AL, Kiemeney LA, Swinkels DW, Sweep FC, den Heijer M. Hoogendoorn EH, et al. Among authors: de vegt f. Clin Chem. 2006 Jan;52(1):104-11. doi: 10.1373/clinchem.2005.055194. Epub 2005 Oct 27. Clin Chem. 2006. PMID: 16254196 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters